These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 2785676

  • 1. Potential virulence factors of Haemophilus influenzae biogroup aegyptius in Brazilian purpuric fever. The Brazilian Purpuric Fever Study Group.
    Carlone GM, Gorelkin L, Gheesling LL, Hoiseth SK, Mulks MH, O'Connor SP, Weyant RS, Myrick JE, Mayer LW, Arko RJ.
    Pediatr Infect Dis J; 1989 Apr; 8(4):245-7. PubMed ID: 2785676
    [No Abstract] [Full Text] [Related]

  • 2. An infant rat model of bacteremia with Brazilian purpuric fever isolates of Haemophilus influenzae biogroup aegyptius (Haemophilus aegyptius). The Brazilian Purpuric Fever Study Group.
    Rubin LG, Carlone GM.
    Pediatr Infect Dis J; 1989 Apr; 8(4):247-8. PubMed ID: 2785677
    [No Abstract] [Full Text] [Related]

  • 3. Development of diagnostic tests for Haemophilus influenzae biogroup aegyptius, the etiologic agent of Brazilian purpuric fever. The Brazilian Purpuric Fever Study Group.
    Brandileone MC, Ajello GW, Bibb WF, Vieira VS, Sottnek FO, Swaminathan B.
    Pediatr Infect Dis J; 1989 Apr; 8(4):243-5. PubMed ID: 2654861
    [No Abstract] [Full Text] [Related]

  • 4. Implications of Haemophilus influenzae biogroup aegyptius hemagglutinins in the pathogenesis of Brazilian purpuric fever.
    Barbosa SF, Hoshino-Shimizu S, Alkmin Md, Goto H.
    J Infect Dis; 2003 Jul 01; 188(1):74-80. PubMed ID: 12825174
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Brazilian purpuric fever, virulence in an animal model of Haemophilus aegyptius (H. influenzae biogroup aegyptius). Grupo de Estudo da Febre Purpúrica Brasileira].
    Brandileone MC, Zanella RC, Tondella ML, Gheesling L, Vieira VS, Carlone GM.
    Rev Inst Med Trop Sao Paulo; 1993 Jul 01; 35(3):259-69. PubMed ID: 8278756
    [Abstract] [Full Text] [Related]

  • 7. Distinguishing clonal characteristics of the Brazilian purpuric fever-producing strain. The Brazilian Purpuric Fever Study Group.
    Mayer LW, Bibb WF, Birkness KA, Irino K, Weyant RS, Reeves MW, Swenson JM.
    Pediatr Infect Dis J; 1989 Apr 01; 8(4):241-3. PubMed ID: 2541399
    [No Abstract] [Full Text] [Related]

  • 8. Brazilian purpuric fever: an epidemiologic and clinical summary. The Brazilian Purpuric Fever Study Group.
    Harrison LH, da Silva GA, Vranjac A, Broome CV.
    Pediatr Infect Dis J; 1989 Apr 01; 8(4):239-41. PubMed ID: 2785675
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of P1-deficient isogenic mutant of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.
    Segada LM, Carlone GM, Gheesling LL, Lesse AJ.
    Microb Pathog; 2000 Mar 01; 28(3):145-55. PubMed ID: 10702356
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical, genetic, and epidemiologic characterization of Haemophilus influenzae biogroup aegyptius (Haemophilus aegyptius) strains associated with Brazilian purpuric fever.
    Brenner DJ, Mayer LW, Carlone GM, Harrison LH, Bibb WF, Brandileone MC, Sottnek FO, Irino K, Reeves MW, Swenson JM.
    J Clin Microbiol; 1988 Aug 01; 26(8):1524-34. PubMed ID: 3262623
    [Abstract] [Full Text] [Related]

  • 13. Role of lipooligosaccharide in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant rats.
    Rubin LG, St Geme JW.
    Infect Immun; 1993 Feb 01; 61(2):650-5. PubMed ID: 8093694
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Brazilian purpuric fever--Mato Grosso, Brazil.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1990 Dec 14; 39(49):903-5. PubMed ID: 2123287
    [Abstract] [Full Text] [Related]

  • 16. Potential virulence-associated factors in Brazilian purpuric fever. Brazilian Purpuric Fever Study Group.
    Carlone GM, Gorelkin L, Gheesling LL, Erwin AL, Hoiseth SK, Mulks MH, O'Connor SP, Weyant RS, Myrick J, Rubin L.
    J Clin Microbiol; 1989 Apr 14; 27(4):609-14. PubMed ID: 2656739
    [No Abstract] [Full Text] [Related]

  • 17. Stable, conserved outer membrane epitope of strains of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.
    Lesse AJ, Gheesling LL, Bittner WE, Myers SD, Carlone GM.
    Infect Immun; 1992 Apr 14; 60(4):1351-7. PubMed ID: 1372293
    [Abstract] [Full Text] [Related]

  • 18. Comparison of lipopolysaccharides from Brazilian purpuric fever isolates and conjunctivitis isolates of Haemophilus influenzae biogroup aegyptius. Brazilian Purpuric Fever Study Group.
    Erwin AL, Munford RS.
    J Clin Microbiol; 1989 Apr 14; 27(4):762-7. PubMed ID: 2786002
    [Abstract] [Full Text] [Related]

  • 19. Brazilian purpuric fever caused by Haemophilus influenzae biogroup aegyptius strains lacking the 3031 plasmid.
    Tondella ML, Quinn FD, Perkins BA.
    J Infect Dis; 1995 Jan 14; 171(1):209-12. PubMed ID: 7798665
    [Abstract] [Full Text] [Related]

  • 20. Brazilian purpuric fever identified in a new region of Brazil. The Brazilian Purpuric Fever Study Group.
    J Infect Dis; 1992 Jun 14; 165 Suppl 1():S16-9. PubMed ID: 1588153
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.